0001104659-19-064171.txt : 20191114 0001104659-19-064171.hdr.sgml : 20191114 20191114160615 ACCESSION NUMBER: 0001104659-19-064171 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191112 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 191220047 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene European Investment Co LLC CENTRAL INDEX KEY: 0001577650 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 191220048 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 908-673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene Switzerland LLC CENTRAL INDEX KEY: 0001661486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 191220049 BUSINESS ADDRESS: STREET 1: AON HOUSE STREET 2: 30 WOODBOURNE AVENUE CITY: PEMBROKE STATE: D0 ZIP: HM 08 BUSINESS PHONE: 4412964803 MAIL ADDRESS: STREET 1: AON HOUSE STREET 2: 30 WOODBOURNE AVENUE CITY: PEMBROKE STATE: D0 ZIP: HM 08 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene Alpine Investment Co., LLC CENTRAL INDEX KEY: 0001581774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 191220050 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: X1 ZIP: 07901 BUSINESS PHONE: 908-673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: X1 ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20080703 4 1 tm1922788d1_4.xml FORM 4 X0306 4 2019-11-12 0 0001439222 AGIOS PHARMACEUTICALS, INC. AGIO 0000816284 CELGENE CORP /DE/ CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 0001577650 Celgene European Investment Co LLC 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 0001661486 Celgene Switzerland LLC AON HOUSE 30 WOODBOURNE AVENUE PEMBROKE D0 HM 08 BERMUDA 0 0 1 0 0001581774 Celgene Alpine Investment Co., LLC 86 MORRIS AVENUE SUMMIT X1 07901 0 0 1 0 Common Stock 2019-11-12 4 P 0 403225 31.00 A 1777824 D Common Stock 624575 I See footnote Common Stock 4010926 I See footnote Common Stock 708333 I See footnote Owned directly by Celgene Switzerland LLC, a wholly-owned subsidiary of Celgene Corporation ("Celgene"). Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Owned directly by Celgene European Investment Company LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Owned directly by Celgene Alpine Investment Co., LLC, a wholly-owned subsidiary of Celgene. Celgene and the other reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. /s/ Kevin Mello, Manager, Celgene European Investment Company LLC 2019-11-14 /s/ Kevin Mello, Manager, Celgene Switzerland LLC 2019-11-14 /s/ Kevin Mello, Manager, Celgene Alpine Investment Co., LLC 2019-11-14 /s/ David V. Elkins, Executive Vice President & Chief Financial Officer, Celgene Corporation 2019-11-14